Institut für Pharmazie, Martin-Luther-Universität Halle-Wittenberg, Wolfgang-Langenbeck-Str. 4, 06120, Halle (Saale), Germany.
Incoatec GmbH, Max-Planck-Str. 2, 21502, Geesthacht, Germany.
ChemMedChem. 2022 Mar 18;17(6):e202200021. doi: 10.1002/cmdc.202200021. Epub 2022 Feb 15.
8-Nitro-4H-benzo[e][1,3]thiazinones (BTZs) are potent in vitro antimycobacterial agents. New chemical transformations, viz. dearomatization and decarbonylation, of two BTZs and their influence on the compounds' antimycobacterial properties are described. Reactions of 8-nitro-2-(piperidin-1-yl)-6-(trifluoromethyl)-4H-benzo[e][1,3]thiazin-4-one and the clinical drug candidate BTZ043 with the Grignard reagent CH MgBr afford the corresponding dearomatized stable 4,5-dimethyl-5H- and 4,7-dimethyl-7H-benzo[e][1,3]thiazines. These methine compounds are structurally characterized by X-ray crystallography for the first time. Reduction of the BTZ carbonyl group, leading to the corresponding markedly non-planar 4H-benzo[e][1,3]thiazine systems, is achieved using the reducing agent (CH ) S ⋅ BH . Double methylation with dearomatization and decarbonylation renders the two BTZs studied inactive against Mycobacterium tuberculosis and Mycobacterium smegmatis, as proven by in vitro growth inhibition assays.
8-硝基-4H-苯并[e][1,3]噻嗪酮(BTZs)是一种有效的体外抗分枝杆菌药物。本文描述了两种 BTZs 的新化学转化,即去芳构化和脱羰,以及它们对化合物抗分枝杆菌特性的影响。8-硝基-2-(哌啶-1-基)-6-(三氟甲基)-4H-苯并[e][1,3]噻嗪-4-酮和临床候选药物 BTZ043 与格氏试剂 CHMgBr 的反应得到了相应的稳定的去芳构化的 4,5-二甲基-5H-和 4,7-二甲基-7H-苯并[e][1,3]噻嗪。这些亚甲化合物首次通过 X 射线晶体学进行了结构表征。使用还原剂(CH)S⋅BH 实现了 BTZ 羰基的还原,生成了相应的明显非平面的 4H-苯并[e][1,3]噻嗪系统。用去芳构化和脱羰进行双重甲基化使研究的两种 BTZs 对结核分枝杆菌和耻垢分枝杆菌失去活性,这已通过体外生长抑制试验得到证明。